Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma

被引:423
作者
Kan, Zhengyan [1 ]
Zheng, Hancheng [2 ]
Liu, Xiao [2 ,3 ]
Li, Shuyu [4 ]
Barber, Thomas D. [4 ]
Gong, Zhuolin [2 ]
Gao, Huan [2 ]
Hao, Ke [5 ]
Willard, Melinda D. [4 ]
Xu, Jiangchun [1 ]
Hauptschein, Robert [1 ]
Rejto, Paul A. [1 ]
Fernandez, Julio [1 ]
Wang, Guan [2 ]
Zhang, Qinghui [2 ]
Wang, Bo [2 ]
Chen, Ronghua [5 ]
Wang, Jian [4 ]
Lee, Nikki P. [6 ]
Zhou, Wei [5 ]
Lin, Zhao [2 ]
Peng, Zhiyu [2 ]
Yi, Kang [2 ]
Chen, Shengpei [2 ]
Li, Lin [2 ]
Fan, Xiaomei [2 ]
Yang, Jie [2 ]
Ye, Rui [2 ]
Ju, Jia [2 ]
Wang, Kai [1 ]
Estrella, Heather [1 ]
Deng, Shibing [1 ]
Wei, Ping [1 ]
Qiu, Ming [1 ]
Wulur, Isabella H. [4 ]
Liu, Jiangang [4 ]
Ehsani, Mariam E. [4 ]
Zhang, Chunsheng [5 ]
Loboda, Andrey [5 ]
Sung, Wing Kin [6 ,7 ]
Aggarwal, Amit
Poon, Ronnie T. [6 ]
Fan, Sheung Tat [6 ]
Wang, Jun [2 ,3 ,8 ,9 ]
Hardwick, James [5 ,10 ]
Reinhard, Christoph [4 ]
Dai, Hongyue [5 ]
Li, Yingrui [2 ]
Luk, John M. [6 ,11 ,12 ,13 ]
Mao, Mao [1 ,10 ]
机构
[1] Pfizer Oncol, San Diego, CA 92121 USA
[2] BGI Shenzhen, Shenzhen 518083, Peoples R China
[3] Univ Copenhagen, Dept Biol, Copenhagen, Denmark
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Merck Res Labs, Boston, MA 02115 USA
[6] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[7] Natl Univ Singapore, Sch Comp, Singapore 117417, Singapore
[8] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark
[9] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia
[10] Asian Canc Res Grp Inc, Wilmington, DE 19808 USA
[11] Natl Univ Singapore, Dept Pharmacol, Singapore 117597, Singapore
[12] Natl Univ Singapore, Dept Surg, Singapore 117597, Singapore
[13] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore
关键词
SOMATIC MUTATIONS; FREQUENT MUTATION; COPY-NUMBER; CANCER; GENE; INHIBITOR; JAK1; SUPPRESSION; ACTIVATION; DISCOVERY;
D O I
10.1101/gr.154492.113
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide and has no effective treatment, yet the molecular basis of hepatocarcinogenesis remains largely unknown. Here we report findings from a whole-genome sequencing (WGS) study of 88 matched HCC tumor/normal pairs, 81 of which are Hepatitis B virus (HBV) positive, seeking to identify genetically altered genes and pathways implicated in HBV-associated HCC. We find beta-catenin to be the most frequently mutated oncogene (15.9%) and TP53 the most frequently mutated tumor suppressor (35.2%). The Wnt/beta-catenin and JAK/STAT pathways, altered in 62.5% and 45.5% of cases, respectively, are likely to act as two major oncogenic drivers in HCC. This study also identifies several prevalent and potentially actionable mutations, including activating mutations of Janus kinase 1 (JAK1), in 9.1% of patients and provides a path toward therapeutic intervention of the disease.
引用
收藏
页码:1422 / 1433
页数:12
相关论文
共 66 条
  • [1] GEOGRAPHIC-VARIATION OF P53 MUTATIONAL PROFILE IN NONMALIGNANT HUMAN LIVER
    AGUILAR, F
    HARRIS, CC
    SUN, T
    HOLLSTEIN, M
    CERUTTI, P
    [J]. SCIENCE, 1994, 264 (5163) : 1317 - 1319
  • [2] Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
    Audeh, M. William
    Carmichael, James
    Penson, Richard T.
    Friedlander, Michael
    Powell, Bethan
    Bell-McGuinn, Katherine M.
    Scott, Clare
    Weitzel, Jeffrey N.
    Oaknin, Ana
    Loman, Niklas
    Lu, Karen
    Schmutzler, Rita K.
    Matulonis, Ursula
    Wickens, Mark
    Tutt, Andrew
    [J]. LANCET, 2010, 376 (9737) : 245 - 251
  • [3] Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion
    Bass, Adam J.
    Lawrence, Michael S.
    Brace, Lear E.
    Ramos, Alex H.
    Drier, Yotam
    Cibulskis, Kristian
    Sougnez, Carrie
    Voet, Douglas
    Saksena, Gordon
    Sivachenko, Andrey
    Jing, Rui
    Parkin, Melissa
    Pugh, Trevor
    Verhaak, Roel G.
    Stransky, Nicolas
    Boutin, Adam T.
    Barretina, Jordi
    Solit, David B.
    Vakiani, Evi
    Shao, Wenlin
    Mishina, Yuji
    Warmuth, Markus
    Jimenez, Jose
    Chiang, Derek Y.
    Signoretti, Sabina
    Kaelin, William G., Jr.
    Spardy, Nicole
    Hahn, William C.
    Hoshida, Yujin
    Ogino, Shuji
    DePinho, Ronald A.
    Chin, Lynda
    Garraway, Levi A.
    Fuchs, Charles S.
    Baselga, Jose
    Tabernero, Josep
    Gabriel, Stacey
    Lander, Eric S.
    Getz, Gad
    Meyerson, Matthew
    [J]. NATURE GENETICS, 2011, 43 (10) : 964 - U67
  • [4] Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
    Beroukhim, Rameen
    Getz, Gad
    Nghiemphu, Leia
    Barretina, Jordi
    Hsueh, Teli
    Linhart, David
    Vivanco, Igor
    Lee, Jeffrey C.
    Huang, Julie H.
    Alexander, Sethu
    Du, Jinyan
    Kau, Tweeny
    Thomas, Roman K.
    Shah, Kinial
    Soto, Horacio
    Perner, Sven
    Prensner, John
    Debiasi, Ralph M.
    Demichelis, Francesca
    Hatton, Charlie
    Rubin, Mark A.
    Garraway, Levi A.
    Nelson, Stan F.
    Liau, Linda
    Mischel, Paul S.
    Cloughesy, Tim F.
    Meyerson, Matthew
    Golub, Todd A.
    Lander, Eric S.
    Mellinghoff, Ingo K.
    Sellers, William R.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (50) : 20007 - 20012
  • [5] Initial genome sequencing and analysis of multiple myeloma
    Chapman, Michael A.
    Lawrence, Michael S.
    Keats, Jonathan J.
    Cibulskis, Kristian
    Sougnez, Carrie
    Schinzel, Anna C.
    Harview, Christina L.
    Brunet, Jean-Philippe
    Ahmann, Gregory J.
    Adli, Mazhar
    Anderson, Kenneth C.
    Ardlie, Kristin G.
    Auclair, Daniel
    Baker, Angela
    Bergsagel, P. Leif
    Bernstein, Bradley E.
    Drier, Yotam
    Fonseca, Rafael
    Gabriel, Stacey B.
    Hofmeister, Craig C.
    Jagannath, Sundar
    Jakubowiak, Andrzej J.
    Krishnan, Amrita
    Levy, Joan
    Liefeld, Ted
    Lonial, Sagar
    Mahan, Scott
    Mfuko, Bunmi
    Monti, Stefano
    Perkins, Louise M.
    Onofrio, Robb
    Pugh, Trevor J.
    Rajkumar, S. Vincent
    Ramos, Alex H.
    Siegel, David S.
    Sivachenko, Andrey
    Stewart, A. Keith
    Trudel, Suzanne
    Vij, Ravi
    Voet, Douglas
    Winckler, Wendy
    Zimmerman, Todd
    Carpten, John
    Trent, Jeff
    Hahn, William C.
    Garraway, Levi A.
    Meyerson, Matthew
    Lander, Eric S.
    Getz, Gad
    Golub, Todd R.
    [J]. NATURE, 2011, 471 (7339) : 467 - 472
  • [6] High-resolution mapping of copy-number alterations with massively parallel sequencing
    Chiang, Derek Y.
    Getz, Gad
    Jaffe, David B.
    O'Kelly, Michael J. T.
    Zhao, Xiaojun
    Carter, Scott L.
    Russ, Carsten
    Nusbaum, Chad
    Meyerson, Matthew
    Lander, Eric S.
    [J]. NATURE METHODS, 2009, 6 (01) : 99 - 103
  • [7] Cancer genomics: from discovery science to personalized medicine
    Chin, Lynda
    Andersen, Jannik N.
    Futreal, P. Andrew
    [J]. NATURE MEDICINE, 2011, 17 (03) : 297 - 303
  • [8] Chow JPH, 2010, ADV EXP MED BIOL, V676, P57
  • [9] Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
    de Lau, Wim
    Barker, Nick
    Low, Teck Y.
    Koo, Bon-Kyoung
    Li, Vivian S. W.
    Teunissen, Hans
    Kujala, Pekka
    Haegebarth, Andrea
    Peters, Peter J.
    van de Wetering, Marc
    Stange, Daniel E.
    van Es, Johan E.
    Guardavaccaro, Daniele
    Schasfoort, Richard B. M.
    Mohri, Yasuaki
    Nishimori, Katsuhiko
    Mohammed, Shabaz
    Heck, Albert J. R.
    Clevers, Hans
    [J]. NATURE, 2011, 476 (7360) : 293 - U57
  • [10] DAVID: Database for annotation, visualization, and integrated discovery
    Dennis, G
    Sherman, BT
    Hosack, DA
    Yang, J
    Gao, W
    Lane, HC
    Lempicki, RA
    [J]. GENOME BIOLOGY, 2003, 4 (09)